The newly listed company serves the Chinese inbound tourism sector in Australia
.jpg)
Baker McKenzie was the legal adviser of Mediland Pharm on its IPO and listing on the ASX.
The cosmetics and health products retailer, which services the Chinese inbound tourism sector in Australia, achieved an initial market capitalisation of $62.5m. Founded in 2002, the company is owned and operated by a first-generation Australian family with Chinese heritage.
With stores in Sydney, Melbourne, and the Gold Coast and partnerships with major Chinese travel agencies that direct large groups of tourists to those shops, the company has become a leading retailer in its sector, Baker McKenzie said.
Bill Fuggle, partner and head of financial services, led the Baker McKenzie team on the deal. He said that the listing helps the company raise capital for expansion. Fuggle was assisted by lawyer Amy Xi.
